Community/Retail

New revisions to the North American Pharmacist Licensure Examination (NAPLEX) will be implemented on November 1, 2015.

An article citing the positive impact of prescription drugs on reducing other medical costs in the Medicaid program was published today by the distinguished peer-reviewed health journal Health Affairs in the September issue.

Mylan has launched a generic equivalent to Bayer's Yasmin birth control tablets.

The FDA has approved the first and only 24-hour aspirin formulation.

Cardinal Health has announced the opening of its Healthcare Supply Chain Innovation Lab, a research and development facility dedicated to reducing the $5 billion in waste in the health care supply chain for devices and implantables.

Gout patients may be at greater risk for atrial fibrillation.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses counseling points that pharmacists can provide to patients on asthma medications.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, talks about how his company supports the expanding role of the pharmacist.

In an effort to demonstrate the power of shared wisdom, provide a place for the HIV community to access and share information and support national HIV advocacy efforts, Janssen has announced the launch of Your Story, Your HIV Wisdom.

Specialty pharmacy isn't just about dispensing medications; it's about providing a higher level of service to which patients are responding.

Take advantage of these 5 tips in your transition to pharmacy school.

The FDA launched a new website in July to provide information about medications approved with Risk Evaluation and Mitigation Strategies (REMS).

Here are some important drug facts to review before Addyi launches in October.

A new CVS Health Research Institute study published in JAMA Internal Medicine is the first to evaluate the impact of narrow pharmacy networks on medication adherence.

Cardinal Health's board of directors has elected Nancy Killefer as an independent director, effective September 14.

The FDA has expanded the use of AstraZeneca's blood thinner ticagrelor (Brilinta) in a 60 mg dose for patients with a history of heart attack.

While laughter may be the best medicine, it can also have adverse effects.

A new report from CVS shows that the decision to drop tobacco actually makes a difference in reducing the number of cigarettes smoked and possibly the population of smokers.

Colchicine (Colcrys) is a promising adjunctive option in secondary prevention of cardiovascular events, probably because of its ability to stop or slow neutrophil reaction to intravascular cholesterol crystals.

Pharmacists are conspicuously absent from treatment teams for cancer survivors.

About 40% of Americans have missed a major life event because of flu symptoms, according to a recent CVS survey.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses some techniques pharmacists can demonstrate for inhaled medications like Dulera and Symbicort.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about some ways smoking cessation can improve patient health and manage chronic conditions.

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks obstacles to managing diabetes, and how pharmacists overcome them.

Sandoz has launched a generic version of Novartis' Exelon Patch for Alzheimer's dementia.

Because current health care practice focuses on diagnosing and prescribing, the need to taper, reduce, or discontinue inappropriate medication therapy receives relatively little attention.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses legislative issues and technology that could affect pharmacy.

Allergan's ceftaroline fosamil is now approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia with a shorter infusion time.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses how community pharmacists can best leverage EHR technology.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses communication obstacles that hinder community pharmacists from playing a more active role in transitions of care.